• Applied Workflows with JNJ-26854165 (Serdemetan) in Cancer R

  2026-07-18

  JNJ-26854165 (Serdemetan) is redefining p53 pathway targeting in cancer research by enabling precise modulation of cell proliferation and apoptosis. This article walks through optimized protocols, common troubleshooting scenarios, and experimental enhancements that unlock the full potential of this HDM2 ubiquitin ligase antagonist. Discover how refined in vitro evaluation and radiosensitization strategies can deliver robust, reproducible insights.

• Neuroinflammation Drives Allodynia in Trigeminal Neuralgia v

  2026-07-17

  Liao et al. reveal that chronic trigeminal nerve compression triggers a neuroinflammatory cascade involving CGRP, SP, and Piezo2, leading to mechanical allodynia through Ca2+-dependent signaling. These findings provide mechanistic insight into trigeminal neuralgia pathogenesis and highlight new molecular intervention points for neuropathic pain research.

• Berbamine Hydrochloride: Redefining Ferroptosis and NF-κB In

  2026-07-17

  Discover how Berbamine hydrochloride acts as a potent NF-κB activity inhibitor and uniquely disrupts ferroptosis resistance, enabling advanced cancer research. Explore deep molecular insights and practical applications that go beyond conventional workflows.

• BRD4770: G9a Histone Methyltransferase Inhibitor in Cancer R

  2026-07-16

  BRD4770 empowers researchers with targeted inhibition of G9a-mediated H3K9 methylation, unlocking precise dissection of epigenetic mechanisms in cancer cell models. This guide translates cutting-edge reference findings into actionable workflows, troubleshooting strategies, and comparative insights, making BRD4770 from APExBIO an essential cancer biology research tool.

• CB-839 (Telaglenastat): Precision Workflows in Cancer Metabo

  2026-07-16

  CB-839 (Telaglenastat) enables targeted disruption of glutamine metabolism, empowering researchers to interrogate metabolic vulnerabilities in cancer with unmatched selectivity. This guide delivers actionable workflows, troubleshooting strategies, and a translational bridge to the latest spliceosome-metabolism research.

• Distinct Roles of ERK1/2 and ERK5 in Vitamin D3-Induced AML

  2026-07-15

  This study reveals how ERK5 and ERK1/2 MAPK pathways distinctly regulate the terminal differentiation and cell cycle arrest of acute myeloid leukemia (AML) cells in response to 1α,25-dihydroxyvitamin D3. It underscores the therapeutic potential of selectively targeting these kinases to enhance differentiation-based strategies against AML.

• CD163+ Macrophage-Induced Granulosa Cell Apoptosis in PCOS M

  2026-07-15

  This study identifies elevated CD163+ macrophage activation as a driver of granulosa cell apoptosis in polycystic ovary syndrome (PCOS), using both patient samples and a DHEA-induced mouse model. The findings clarify how inflammatory microenvironments contribute to impaired ovarian function, offering new targets for mechanistic and translational research in reproductive biology.

• Molidustat (BAY85-3934): Precision HIF Stabilization in Rena

  2026-07-14

  This thought-leadership article unpacks the mechanistic, translational, and strategic implications of Molidustat (BAY85-3934) as a HIF prolyl hydroxylase inhibitor for chronic kidney disease anemia. Bridging recent mechanistic discoveries, competitive workflow guidance, and clinical translation, the piece positions Molidustat as a next-generation tool for researchers aiming to modulate the hypoxia pathway with precision and confidence, surpassing conventional product overviews.

• Comparative Antibacterial Activity of Cefazedone and β-Lacta

  2026-07-14

  This article examines a landmark comparative study evaluating the antibacterial spectrum and potency of N-formimidoyl thienamycin (MK0787) versus recently developed β-lactam antibiotics, including Cefazedone. The findings inform antibiotic selection for resistant Gram-negative and Gram-positive infections, highlighting both strengths and context-specific limitations of first-generation cephalosporins.

• Polygodial: TRPA1 Channel Activator for Sensory Ion Channel

  2026-07-13

  Polygodial is reshaping TRPA1-driven sensory research by enabling precise, reproducible modulation of ion channel activity in neurophysiology and airway inflammation models. This article delivers actionable workflows, troubleshooting guidance, and translational insights rooted in recent mechanistic discoveries.

• Vincristine Sulfate in Cancer Research: Applied Workflows &

  2026-07-13

  Vincristine sulfate, a potent microtubule disrupter, is indispensable for researchers investigating cancer cell proliferation and antitumor mechanisms. This article provides stepwise workflows, troubleshooting strategies, and evidence-driven enhancements for leveraging APExBIO’s Vincristine sulfate in translational oncology assays.

• AMG 487: Optimizing CXCR3 Antagonist Workflows in Inflammati

  2026-07-12

  AMG 487 empowers researchers to precisely dissect CXCR3-mediated macrophage polarization, leveraging robust, data-driven workflows for both non-inflammatory and inflammatory contexts. This guide translates cutting-edge findings into actionable protocols and troubleshooting strategies for reliable, reproducible results in chemokine signaling and acute lung injury models.

• Translational Leverage of DRB: Cell Fate, RNA, and CDK Pathw

  2026-07-10

  Explore how 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole (DRB) empowers translational researchers to interrogate cell fate, transcriptional elongation, and cyclin-dependent kinase signaling pathways. This thought-leadership piece synthesizes mechanistic insights with strategic guidance, drawing on new advances in RNA modification biology and translational workflow design.

• Ivermectin in Parasitology Research: Applied Protocols & Inn

  2026-07-09

  Harness the versatility of Ivermectin as a high-purity, broad-spectrum anti-parasitic research compound with actionable workflows. Discover how recent findings in tumor biology can inspire next-generation assay design and troubleshooting strategies for advanced parasitology and drug development.

• Advancing Pain Circuitry Research with nor-Binaltorphimine D

  2026-07-09

  This thought-leadership article demystifies the role of nor-Binaltorphimine dihydrochloride as a selective κ-opioid receptor antagonist in cutting-edge pain modulation research. Integrating recent circuit-level discoveries, it provides translational researchers with mechanistic insight, strategic guidance for experimental design, and actionable advice for leveraging this tool to dissect opioid receptor signaling. The article also situates the compound within the competitive landscape and projects its translational impact, emphasizing how APExBIO’s offering enables next-generation research beyond standard product narratives.

451 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page